Supernus Pharmaceuticals reported $58.16M in Ordinary Share Capital for its fiscal quarter ending in June of 2026.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Aurora Cannabis CAD 63.31M 4.36M Jun/2026
Bristol-Myers Squibb USD 2.04B 7M Jun/2026
Canopy Growth CAD 422.07M 53.78M Mar/2026
Cara Therapeutics USD 9.38M 2.01K Mar/2026
Corcept Therapeutics USD 109.36M 1.44M Sep/2026
Eisai JPY 282.46M 0 Sep/2026
Eli Lilly USD 943.5M 3.33M Mar/2026
Novo Nordisk DKK 4.43B 13.25M Jun/2026
Pacira USD 39.9M 75K Sep/2026
Perrigo USD 138.8M 700K Sep/2026
Pfizer USD 5.7B 1000K Sep/2026
Supernus Pharmaceuticals USD 58.16M 124K Jun/2026
United Therapeutics USD 42.38M 295K Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026